Participants receiving tirzepatide at maximum doses achieved average weight losses of 2022% of baseline body weight, while semaglutide trials reported 1417% reductions
The British journal of nutrition, 124(11), 11211132
However, future prospective randomized, controlled trials are needed to explore the role of natural bioactive compounds as well as their supplements on health status, lung function and risk of COPD development
Tirzepatide has demonstrated remarkable weight loss outcomes in clinical trials, with participants losing up to 22% of body weight at higher maintenance doses
The distinction is between the compound being legal for medical use and a specific cosmetic indication receiving formal FDA approval
Increase fiber intake slowly and drink enough water to improve fibers effect